Literature DB >> 12431228

Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations.

Anneloes Dirks1, Lucianne Groenink, J Adriaan Bouwknecht, Theo H Hijzen, Jan Van Der Gugten, Eric Ronken, J Sjef Verbeek, Jan G Veening, Pieter J W C Dederen, Aniko Korosi, Louise F Schoolderman, Eric W Roubos, Berend Olivier.   

Abstract

To gain a greater insight into the relationship between hyperactivity of the corticotropin-releasing hormone (CRH) system and autonomic and physiological changes associated with chronic stress, we developed a transgenic mouse model of central CRH overproduction. The extent of central and peripheral CRH overexpression, and the amount of bioactive CRH in the hypothalamus were determined in two lines of CRH-overexpressing (CRH-OE) mice. Furthermore, 24 h patterns of body temperature, heart rate, and activity were assessed using radiotelemetry, as well as cumulative water and food consumption and body weight gain over a 7-day period. CRH-OE mice showed increased amounts of CRH peptide and mRNA only in the central nervous system. Despite the presence of the same CRH transgene in their genome, only in one of the two established lines of CRH-OE mice (line 2122, but not 2123) was overexpression of CRH associated with increased levels of bioactive CRH in the hypothalamus, increased body temperature and heart rate (predominantly during the light (inactive) phase of the diurnal cycle), decreased heart rate variability during the dark (active) phase, and increased food and water consumption, when compared with littermate wildtype mice. Because line 2122 of the CRH transgenic mice showed chronic stress-like neuroendocrine and autonomic changes, these mice appear to represent a valid animal model for chronic stress and might be valuable in the research on the consequences of CRH excess in situations of chronic stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431228     DOI: 10.1046/j.1460-9568.2002.02245.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  25 in total

Review 1.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

2.  Corticotropin-releasing factor-overexpressing mice exhibit reduced neuronal activation in the arcuate nucleus and food intake in response to fasting.

Authors:  Andreas Stengel; Miriam Goebel; Mulugeta Million; Mary P Stenzel-Poore; Peter Kobelt; Hubert Mönnikes; Yvette Taché; Lixin Wang
Journal:  Endocrinology       Date:  2008-09-11       Impact factor: 4.736

3.  Modulation of gastric motility by brain-gut peptides using a novel non-invasive miniaturized pressure transducer method in anesthetized rodents.

Authors:  Guillaume Gourcerol; David W Adelson; Mulugeta Million; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2011-01-22       Impact factor: 3.750

Review 4.  Sex-biased stress signaling: the corticotropin-releasing factor receptor as a model.

Authors:  Rita J Valentino; Debra Bangasser; Elisabeth J Van Bockstaele
Journal:  Mol Pharmacol       Date:  2012-12-13       Impact factor: 4.436

5.  Enhanced pelvic responses to stressors in female CRF-overexpressing mice.

Authors:  M Million; L Wang; M P Stenzel-Poore; S C Coste; P Q Yuan; C Lamy; J Rivier; T Buffington; Y Taché
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-28       Impact factor: 3.619

6.  Identification of SPRED2 (sprouty-related protein with EVH1 domain 2) as a negative regulator of the hypothalamic-pituitary-adrenal axis.

Authors:  Melanie Ullrich; Karin Bundschu; Peter M Benz; Marco Abesser; Ruth Freudinger; Tobias Fischer; Julia Ullrich; Thomas Renné; Ulrich Walter; Kai Schuh
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

7.  Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing mice.

Authors:  Nina Dedic; Chadi Touma; Cristoph P Romanowski; Marcel Schieven; Claudia Kühne; Martin Ableitner; Ailing Lu; Florian Holsboer; Wolfgang Wurst; Mayumi Kimura; Jan M Deussing
Journal:  Cell Mol Neurobiol       Date:  2011-12-25       Impact factor: 5.046

8.  Effects of fluoxetine on CRF and CRF1 expression in rats exposed to the learned helplessness paradigm.

Authors:  Georgina Valeria Fernández Macedo; María Laura Cladouchos; Laura Sifonios; Pablo Martín Cassanelli; Silvia Wikinski
Journal:  Psychopharmacology (Berl)       Date:  2012-09-08       Impact factor: 4.530

Review 9.  The hypothalamic-pituitary-adrenal axis as a substrate for stress resilience: Interactions with the circadian clock.

Authors:  Scott A Kinlein; Ilia N Karatsoreos
Journal:  Front Neuroendocrinol       Date:  2019-12-19       Impact factor: 8.606

10.  CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents.

Authors:  T N Douma; M J Millan; D Boulay; G Griebel; P M Verdouw; K G Westphal; B Olivier; L Groenink
Journal:  Psychopharmacology (Berl)       Date:  2013-11-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.